Aim: To predict prognosis in patients with acute-on-chronic hepatitis (AOCH) using the model for end-stage liver disease (MELD) scoring system and to study the effects of age, sex, etiology, low serum ...

November 20, 2007 -- After a temporary increase in death rate among those on the waiting list, the new Model for End-Stage Liver Disease (MELD) criteria for allocating livers for transplant have ...

Please provide your email address to receive an email when new articles are posted on . On-treatment improvement of MELD scores correlated with reduced risk for all-cause mortality and hepatic events ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patient survival was no different for living donor liver transplant recipients with a MELD score ...

Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...

The Model for End-stage Liver Disease (MELD) score—derived from serum total bilirubin and creatinine levels, plus the international normalized ratio—is commonly used in the US to assess patients' ...

Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...

Laboratory traits used in the calculation of sodium-adjusted model for end-stage liver disease (MELDNa) scores placed women at a distinct disadvantage, researchers reported. In an electronic health ...

Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in ...

Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver transplant, more likely to receive a transplant, and less ...